Spruce Biosciences, Inc.'s latest layoff filing, on April 25, 2025, states charges of approximately $0.9 million. As of November 15, 2026, it has reported 2 exit or restructuring plans to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, April 25, 2025).
10 companies announced layoffs this week, 1 had other signals.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| UPWORK, INC | announced layoffs | |
| PVH CORP. /DE/ | announced layoffs | |
| Battelle | filed a layoff notice for 15 employees | |
| TidalHealth Primary Care | filed a layoff notice for 5 employees | |
| Phunware, Inc. | announced layoffs |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of Spruce Biosciences, Inc.
Free to see. No signup.
People from Spruce Biosciences, Inc. who say they are open to work
Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.
Loading the list…
Affected by the Spruce Biosciences, Inc. layoff? Add yourself to the open-to-work list, free
Your entry
Spruce Biosciences, Inc. reported 2 exit or restructuring plans on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did Spruce Biosciences have layoffs in 2025? What its filings say
Spruce Biosciences, Inc. (CIK 1683553) reported 2 exit or restructuring plans to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2025-04-25
Expected charges
The Company estimates that it will incur approximately $0.9 million in cash charges in connection with the workforce reduction, consisting of expenses related to severance payments and healthcare coverage assistance and related costs.
Timing
The Company expects that most of these estimated charges will be recorded in the second quarter of 2025 and the execution of the workforce reduction will be completed during the second quarter of 2025.
Form 8-K filed 2024-03-13
Expected charges
The Company estimates that it will incur approximately $0.4 million in cash charges in connection with the Realignment Plan, consisting of expenses related to employee severance payments and healthcare coverage assistance and related costs.
Timing
The Company expects that the majority of these estimated charges will be recorded in the second quarter of 2024 and that the execution of the Realignment Plan will be substantially complete during the second quarter of 2024.
Also on the record for Spruce Biosciences, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 14, 2026 | Stake report, Schedule 13G, by AWM Investment Company, Inc. | 5.1% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G, by OrbiMed Advisors LLC | 4.8% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by ADAR1 Capital Management, LLC | 2.5% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by Kenneth Griffin | 1.9% of the class | 5%+ stakes | Source |
| August 4, 2026 | Stake report, Schedule 13G/A, by Integrated Core Strategies (US) LLC | 5.8% of the class | 5%+ stakes | Source |
| July 30, 2026 | Stake report, Schedule 13G, by BlackRock, Inc. | 6.8% of the class | 5%+ stakes | Source |
| July 27, 2026 | Leadership change: Adrian Quartel appointed, Chief Medical Officer | — | Leadership changes | Source |
| July 27, 2026 | Stake report, Schedule 13G, by Orin Hirschman | 9.1% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Alyeska Investment Group, L.P. | 4.49% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Citadel Advisors LLC | 5.1% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Squadron Master Fund LP | 0.9% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Wellington Management Group LLP | 3.6% of the class | 5%+ stakes | Source |
Keep reading
More on Spruce Biosciences, Inc. and the records around it.
Spruce Biosciences, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Leadership changes Jul 2026
- Form D filing Oct 2025
- Who owns it
Companies that share a holder
- Rock Springs Capital Management LP also filed stake reports on 1 other company: TALPHERA, INC. (Sep 2025)
- ExodusPoint Capital Management, LP also filed stake reports on 3 other companies: RE/MAX Holdings, Inc. (Aug 2026), Keros Therapeutics, Inc. (Feb 2026), ALT5 Sigma Corp (Aug 2025)
- The Carlyle Group Inc. also filed stake reports on 7 other companies: SunPower Inc. (Aug 2026), Q32 Bio Inc. (Jul 2026), Medline Inc. (May 2026)
Watch Spruce Biosciences, Inc.
Get an email when Spruce Biosciences, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Spruce Biosciences, Inc.?
Want the whole picture on Spruce Biosciences, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Spruce Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Spruce Biosciences, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 31 records.
Tools for this story
Each opens in a new tab, filled in for Spruce Biosciences, Inc.. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Who owns Spruce Biosciences, Inc.? Owners, funding and legal record
Cite this page
https://mentionfox.com/layoffs/spruce-biosciences